New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
BU professor receives grant to study endothelial cell health in cardiometabolic disease

BU professor receives grant to study endothelial cell health in cardiometabolic disease

Naomi Hamburg, MD, the Joseph A. Vita Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, has been awarded a five-year, $3.7 million grant from the National Heart,
World medicine November 09,2023
BU professor receives grant to study endothelial cell health in cardiometabolic disease

BU professor receives grant to study endothelial cell health in cardiometabolic disease

Naomi Hamburg, MD, the Joseph A. Vita Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, has been awarded a five-year, $3.7 million grant from the National Heart,
World medicine November 09,2023
Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Leukemia, characterized by unregulated clonal proliferation of hematopoietic stem cells, is the second leading cause of death in children. The role of the intestinal microbiota is closely linked to re
World medicine November 09,2023
Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Gut health and leukemia: Exploring the crucial connection between diet and microbiota changes

Leukemia, characterized by unregulated clonal proliferation of hematopoietic stem cells, is the second leading cause of death in children. The role of the intestinal microbiota is closely linked to re
World medicine November 09,2023
Real-World Analysis Supports Use of Brexu-Cel in Relapsed/Refractory MCL

Real-World Analysis Supports Use of Brexu-Cel in Relapsed/Refractory MCL

The real-world efficacy and safety of brexucabtagene autoleucel (brexu-cel; Tecartus) were similar to the outcomes seen in the phase 2 ZUMA-2 trial (NCT02601313), regardless of patients’ treatment his
World medicine November 09,2023
Real-World Analysis Supports Use of Brexu-Cel in Relapsed/Refractory MCL

Real-World Analysis Supports Use of Brexu-Cel in Relapsed/Refractory MCL

The real-world efficacy and safety of brexucabtagene autoleucel (brexu-cel; Tecartus) were similar to the outcomes seen in the phase 2 ZUMA-2 trial (NCT02601313), regardless of patients’ treatment his
World medicine November 09,2023
Long-Term ROSEWOOD Data Confirm Efficacy of Zanubrutinib Plus Obinutuzumab in R/R Follicular Lymphoma

Long-Term ROSEWOOD Data Confirm Efficacy of Zanubrutinib Plus Obinutuzumab in R/R Follicular Lymphoma

The addition of zanubrutinib (Brukinsa) to obinutuzumab (Gazyva) produced superior clinical activity, prolonged survival, and had a favorable toxicity profile compared with obinutuzumab alone in heavi
World medicine November 09,2023
Long-Term ROSEWOOD Data Confirm Efficacy of Zanubrutinib Plus Obinutuzumab in R/R Follicular Lymphoma

Long-Term ROSEWOOD Data Confirm Efficacy of Zanubrutinib Plus Obinutuzumab in R/R Follicular Lymphoma

The addition of zanubrutinib (Brukinsa) to obinutuzumab (Gazyva) produced superior clinical activity, prolonged survival, and had a favorable toxicity profile compared with obinutuzumab alone in heavi
World medicine November 09,2023
Can AI outshine human experts in reviewing scientific papers?

Can AI outshine human experts in reviewing scientific papers?

In a recent paper study posted to thearXiv, preprint* server researchers developed and validated a large language model (LLM) aimed at generating helpful feedback on scientific papers. Based on
World medicine November 09,2023
Can AI outshine human experts in reviewing scientific papers?

Can AI outshine human experts in reviewing scientific papers?

In a recent paper study posted to thearXiv, preprint* server researchers developed and validated a large language model (LLM) aimed at generating helpful feedback on scientific papers. Based on
World medicine November 09,2023
Survival Outcomes May Be Impacted By Socio-Racial Factors in Primary Myelofibrosis

Survival Outcomes May Be Impacted By Socio-Racial Factors in Primary Myelofibrosis

A retrospective analysis of the Surveillance, Epidemiology, and End Results (SEER) database emphasized the potential impact of specific socio-racial factors, such as race, sex, and age, on survival ou
World medicine November 09,2023
Survival Outcomes May Be Impacted By Socio-Racial Factors in Primary Myelofibrosis

Survival Outcomes May Be Impacted By Socio-Racial Factors in Primary Myelofibrosis

A retrospective analysis of the Surveillance, Epidemiology, and End Results (SEER) database emphasized the potential impact of specific socio-racial factors, such as race, sex, and age, on survival ou
World medicine November 09,2023
Study: 60% of UK adults struggle to talk about health concerns with their doctors

Study: 60% of UK adults struggle to talk about health concerns with their doctors

Leading telehealth provider, Asda Online Doctor, conducted a nationwide survey to gauge public perceptions and usage of AI in relation to medical issues. The results revealed a concerning trend, with
World medicine November 09,2023
Study: 60% of UK adults struggle to talk about health concerns with their doctors

Study: 60% of UK adults struggle to talk about health concerns with their doctors

Leading telehealth provider, Asda Online Doctor, conducted a nationwide survey to gauge public perceptions and usage of AI in relation to medical issues. The results revealed a concerning trend, with
World medicine November 09,2023
New discovery sheds light on how BRCA1 mutations cause cancer in women

New discovery sheds light on how BRCA1 mutations cause cancer in women

Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at
World medicine November 09,2023
New discovery sheds light on how BRCA1 mutations cause cancer in women

New discovery sheds light on how BRCA1 mutations cause cancer in women

Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at
World medicine November 09,2023
Midbody remnant found to play role in cancer spread

Midbody remnant found to play role in cancer spread

Once thought to be the trash can of the cell, a little bubble of cellular stuff called the midbody remnant is actually packing working genetic material with the power to change the fate of other cells
World medicine November 09,2023
Midbody remnant found to play role in cancer spread

Midbody remnant found to play role in cancer spread

Once thought to be the trash can of the cell, a little bubble of cellular stuff called the midbody remnant is actually packing working genetic material with the power to change the fate of other cells
World medicine November 09,2023
Loving parent-child relationships boost prosociality and mental health

Loving parent-child relationships boost prosociality and mental health

A loving bond between parents and their children early in life significantly increases the child's tendency to be 'prosocial', and act with kindness and empathy towards others, research in
World medicine November 09,2023
Loving parent-child relationships boost prosociality and mental health

Loving parent-child relationships boost prosociality and mental health

A loving bond between parents and their children early in life significantly increases the child's tendency to be 'prosocial', and act with kindness and empathy towards others, research in
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com